Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
United Therapeutics Insider Sold Shares Worth $5,583,418, According to a Recent SEC Filing

United Therapeutics Insider Sold Shares Worth $5,583,418, According to a Recent SEC Filing

MT newswireMT newswire2026/10/28 20:37
04:37 PM EDT, 10/28/2026 (MT Newswires) -- Martine A Rothblatt, Director, Chairperson & CEO, on October 27, 2026, sold 9,500 shares in United Therapeutics (UTHR) for $5,583,418. Following the Form 4 filing with the SEC, Rothblatt has control over a total of 668,728 common shares of the company, with 40,513 shares held directly and 628,215 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1082554/000110657826000173/xslF345X05/primarydocument.xml
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Google (GOOGL.US) warns that new Australian cybersecurity regulations may cut off minors' access to Gmail

Google stated that a new cybersecurity bill in Australia could prevent minors from using Gmail.

智通财经•2026/11/09 07:32
Google (GOOGL.US) warns that new Australian cybersecurity regulations may cut off minors' access to Gmail

"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.

Dental treatment company vVardis has announced the terms for its $214 million US IPO.

智通财经•2026/11/09 06:41
"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.